AEMD · Aethlon Medical Inc
The latest filing no longer states the doubt (first flagged Jun 10, 2026).
View the 10-Q filed Aug 13, 2026Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $0 | $574.25K | $294.17K | $659.1K | $650.19K | $229.63K | $149.63K | $392.07K | $886.57K | $762.42K | $1.62M | $1.23M | $1.36M | — | |
| $1.94M | $1.91M | $2.21M | $2.52M | $2.75M | $2.34M | $2.07M | $927K | $896K | $586K | $673K | $782K | $1.03M | $1.51M | $1.44M | — | — | |
| $2.62M | $2.7M | $3.24M | $3.9M | $4.48M | $3.46M | $2.46M | $1.55M | $953.48K | $792.6K | $849.49K | $929.01K | $907.12K | $931.11K | $746.1K | $852.58K | $542.23K | |
| — | $550 | $550 | $550 | $550 | $54.75K | $550 | $9164 | $9164 | $9164 | $9165 | $9000 | $9000 | $9000 | $9000 | $9000 | — | |
| — | $323.65K | $339.56K | $359.06K | $240.89K | $123.69K | $39.94K | $26.37K | $30.7K | $35.66K | $32.41K | $38.52K | $37.35K | $21.09K | $10.48K | $17.22K | $19.1K | |
| $7.08M | $7.29M | $9.34M | $12.64M | $12.47M | $10.72M | $8.55M | $6.58M | $6.23M | $4.98M | $6.49M | $5.27M | $4.76M | $4.68M | $4.81M | $4.47M | $4.56M | |
| -$7.08M | -$7.29M | -$9.34M | -$12.64M | -$11.9M | -$10.42M | -$7.89M | -$5.93M | -$6M | -$4.83M | -$6.1M | -$4.38M | -$3.99M | -$3.06M | -$3.58M | -$3.11M | -$4.56M | |
| — | — | — | — | -2072.05% | -3542.53% | -1197.31% | -912.04% | -2612.53% | -3228.82% | -1555.41% | -494.58% | -523.71% | -188.2% | -290.68% | -229.06% | — | |
| — | -$6.97M | -$9M | -$12.28M | -$11.66M | -$10.3M | -$7.85M | -$5.9M | -$5.97M | -$4.8M | -$6.07M | -$4.35M | -$3.96M | -$3.03M | -$3.56M | -$3.1M | -$4.54M | |
| — | $14.37K | $10.11K | — | — | — | — | — | — | — | — | $125.64K | $298K | $1.29M | — | — | — | |
| — | $156.53K | $298.12K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $142.16K | -$4.05M | — | — | — | -$1580 | -$450.05K | -$220.49K | — | — | — | — | $10.38M | $1.32M | $5M | -$1.15M | |
| — | -$7.15M | -$13.39M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| -$6.94M | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M | -$7.89M | -$6.37M | -$6.19M | -$5.68M | -$7.28M | -$4.87M | -$6.8M | -$13.36M | -$4.89M | -$8.11M | -$5.71M | |
| — | — | — | — | -2094.89% | -3540.9% | -1196.58% | -980.33% | -2697.75% | -3795.86% | -1855.81% | -549.57% | -891.53% | -822.61% | -397.73% | -596.59% | — | |
| $413 | — | — | — | $0 | -$4794 | -$4790 | -$6093 | -$24.79K | -$20.28K | -$30.61K | -$86.29K | -$182.34K | -$81.73K | $0 | — | — | |
| — | -$7.17M | -$13.4M | -$12.21M | -$12.04M | -$10.42M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$53.05 | -$428.85 | -$1,943.50 | -$2,344.00 | -$2,840.00 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$53.05 | -$428.85 | -$1,943.50 | -$2,344.00 | -$2,840.00 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 134.79K | 31.22K | 6281.94 | 5134.36 | 3689.2418 | 3022.721 | 853.71 | 302.0785 | 3079.2685 | 1941.0593 | 1848.4238 | 1398.6118 | 48.51K | 37.31K | 25.44K | 17.4K |
| shares | — | 134.79K | 31.22K | 6281.94 | 5134.36 | 3689.2418 | 3022.721 | 853.71 | 302.0785 | 3079.2685 | 1941.0593 | 1848.4238 | 1398.6118 | 970.2948 | — | 25.44K | 17.4K |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 35 similar-size Medical Devices companies (of 148 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2022 | FY2021 |
|---|---|---|
| Aethlon | $294,165 | $659,104 |
| ESI | $0 | $0 |
By Product & Service (USD)
| Component | FY2022 | FY2021 |
|---|---|---|
| Govt Contract and Grant Revenue | $294,165 | $659,104 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2022 | FY2021 |
|---|---|---|
| ESI | -$23,971 | -$23,952 |
| Aethlon | -$10,396,914 | -$7,867,547 |
Operating Margin by Segment (%)
| Component | FY2022 | FY2021 |
|---|---|---|
| Aethlon | -3534.4% | -1193.7% |